LeMaitre Vascular recalled one unit of its Collagen Vascular Graft on September 25, 2025. The device was packed in the wrong size labeled outer packaging, posing a high hazard to patients. Health providers and patients should stop using this device immediately and follow the recall instructions.
The device was incorrectly packed in the wrong size labeled outer packaging.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact LeMaitre Vascular, Inc. or your healthcare provider for instructions. Notification method: Letter
The recalled product is the Artegraft Collagen Vascular Graft, REF: AG1015. The device is part of a UDI-DI with the number 00316837000343. It was distributed only in Arkansas.
The device's incorrect packing in the wrong size labeled outer packaging poses a significant risk to patients. Mislabeling can lead to improper usage, which may result in serious complications.
No specific incidents or injuries have been reported regarding this recall. The risk level remains high due to potential patient harm from using the incorrectly sized graft.
Stop using the Artegraft Collagen Vascular Graft immediately. Contact LeMaitre Vascular, Inc. or your healthcare provider for further instructions and potential returns.
For more information, contact LeMaitre Vascular at the number provided in the recall letter or visit their website.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.